Jura Health
Jura Health provides rapid whole genome sequencing (WGS) and on-demand genetic counseling through its Emerge™ platform, enabling patients to receive diagnostic results in as early as four weeks. The platform addresses the lengthy average diagnosis time of six years for rare diseases by offering accessible genetic testing and support at no cost to patients.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Software Only
Funding
Founders
Product
Problem
The average diagnosis time for rare diseases is approximately six years, which can significantly delay access to potentially disease-altering or life-saving treatments and impact symptom management. Traditional diagnostic processes often lack accessibility and affordability, creating barriers for patients seeking timely genetic testing and counseling.
Solution
Jura Health's Emerge™ platform accelerates the diagnosis of rare diseases by combining rapid whole genome sequencing (WGS) with on-demand genetic counseling. The platform aims to provide patients and their healthcare providers with accessible and affordable genetic testing and support. By delivering diagnostic results in as early as four weeks, Emerge™ seeks to reduce the lengthy diagnostic delays associated with rare diseases, enabling earlier intervention and improved patient outcomes. The platform offers a comprehensive approach to genetic testing, counseling, and support, streamlining the diagnostic journey for individuals with suspected rare conditions.
Target Audience
The primary target audience includes individuals suspected of having rare diseases, their families, and healthcare providers seeking to expedite the diagnostic process and access genetic counseling resources.
Features
- Rapid whole genome sequencing (WGS) with results available in as early as four weeks.
- On-demand genetic counseling services to interpret results and guide next steps.
- Patient support resources integrated into the Emerge™ platform.
- Accessible platform available to patients and healthcare providers.
- Approved provider for Colorado Medicaid, expanding access to genetic testing for eligible individuals.